| 产品描述: | PF-06648671 is a novel, brain-penetrable, and orally active γ-secretase modulator (GSM). PF-06648671 reduces Aβ42 and Aβ40, with concomitant increases in Aβ37 and Aβ38 in vitro. PF-06648671 is used for the study of Alzheimer’s disease. |
| 靶点: |
γ-secretase |
| 体外研究: |
在基于细胞的测定中,PF-06648671 减少 Aβ42 和 Aβ40,同时增加 Aβ37 和 Aβ38,而不抑制 Notch 或其他底物的裂解。 |
| 体内研究: |
PF-06648671 在动物急性口服给药后可减少大脑和 CSF 中的 Aβ42。 |
| 参考文献: |
1. Jae Eun Ahn, et al. Pharmacokinetic and Pharmacodynamic Effects of a γ-Secretase Modulator, PF-06648671, on CSF Amyloid-β Peptides in Randomized Phase I Studies. Clin Pharmacol Ther 2020 Jan;107(1):211-220.
|
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.856 ml |
9.278 ml |
18.556 ml |
| 5 mM |
0.371 ml |
1.856 ml |
3.711 ml |
| 10 mM |
0.186 ml |
0.928 ml |
1.856 ml |
| 50 mM |
0.037 ml |
0.186 ml |
0.371 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |